Skip to content

A study for safety evaluation of excessive intake of Lactic acid bacterium-powder

A study for safety evaluation of excessive intake of Lactic acid bacterium-powder - Safety evaluation of excessive intake of Lactic acid bacterium-powder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043374
Enrollment
20
Registered
2021-02-21
Start date
2021-02-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intake of Lactic acid bacterium-powder for 4 weeks

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Subjects aged more than 20 years, less than 65 years. 2)Subjects who received an enough explanation of the test objectives and detail, who have consent ability, who are willing to participate with well understandings and who have signed the informed consent document.

Exclusion criteria

Exclusion criteria: 1)Subjects who have a history of serious illness. 2)Subjects who are under treatment with medication for lifestyle-related disease (diabetes, hypertension, dyslipidemia). 3)Subjects who have digestive tract diseases that affect digestion and absorption, and have had a history of gastrointestinal surgery (excluding appendicitis). 4)Subjects who have a medical history of serious allergy to medicine, food and pollen. 5)Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study. 6)Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. 7)Subjects who are planning to participate in other clinical studies. 8)Subjects who are judged unsuitable for participating in this study by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Adverse event and side effect

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026